US Stock MarketDetailed Quotes

Structure Therapeutics (GPCR)

Watchlist
  • 37.840
  • -0.480-1.25%
Close May 12 16:00 ET
  • 38.290
  • +0.450+1.19%
Pre 05:08 ET
2.69BMarket Cap-14.33P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Structure Therapeutics (GPCR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
58.72%89.38M
18.06%186.81M
-129.20%-13.74M
60.98%73.79M
111.46%70.45M
75.89%56.31M
53.96%158.23M
51.84%47.06M
75.31%45.84M
28.20%33.32M
Selling and administrative expenses
70.13%22.87M
24.57%61.55M
29.45%17.57M
11.78%14.8M
39.72%15.74M
18.60%13.44M
51.24%49.41M
23.94%13.57M
53.40%13.24M
71.32%11.27M
-General and administrative expense
70.13%22.87M
24.57%61.55M
29.45%17.57M
11.78%14.8M
39.72%15.74M
18.60%13.44M
51.24%49.41M
23.94%13.57M
53.40%13.24M
71.32%11.27M
Research and development costs
55.15%66.51M
107.01%225.26M
105.12%68.69M
80.96%58.99M
148.12%54.71M
107.30%42.87M
55.22%108.81M
67.08%33.49M
86.11%32.6M
13.60%22.05M
Other operating expenses
----
---100M
----
----
----
----
----
----
----
----
Operating profit
-58.72%-89.38M
-18.06%-186.81M
129.20%13.74M
-60.98%-73.79M
-111.46%-70.45M
-75.89%-56.31M
-53.96%-158.23M
-51.84%-47.06M
-75.31%-45.84M
-28.20%-33.32M
Net non-operating interest income expense
42.03%13.6M
-0.39%35.87M
-14.30%9.19M
-31.53%8.18M
21.73%8.93M
59.39%9.58M
168.93%36.01M
73.46%10.72M
344.61%11.95M
159.65%7.34M
Total other finance cost
-42.03%-13.6M
0.39%-35.87M
14.30%-9.19M
31.53%-8.18M
-21.73%-8.93M
-59.39%-9.58M
-168.93%-36.01M
-73.46%-10.72M
-344.61%-11.95M
-159.65%-7.34M
Other net income (expense)
10.25M
Special income (charges)
----
--10.25M
----
----
----
----
--0
----
----
----
-Gain on sale of property,plant,equipment
----
--10.25M
----
----
----
----
--0
----
----
----
Income before tax
-62.14%-75.78M
-15.11%-140.69M
191.28%33.17M
-93.61%-65.6M
-136.80%-61.52M
-79.70%-46.74M
-36.73%-122.22M
-46.46%-36.34M
-44.46%-33.89M
-12.17%-25.98M
Income tax
93.88%190K
66.13%515K
25.00%170K
17.39%108K
162.26%139K
237.93%98K
31.36%310K
143.59%136K
-77.28%92K
-55.08%53K
Net income
-62.21%-75.97M
-15.24%-141.2M
190.47%33M
-93.40%-65.71M
-136.85%-61.66M
-79.88%-46.83M
-36.72%-122.53M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
Net income continuous Operations
-62.21%-75.97M
-15.24%-141.2M
190.47%33M
-93.40%-65.71M
-136.85%-61.66M
-79.88%-46.83M
-36.72%-122.53M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
Minority interest income
Net income attributable to the parent company
-62.21%-75.97M
-15.24%-141.2M
190.47%33M
-93.40%-65.71M
-136.85%-61.66M
-79.88%-46.83M
-36.72%-122.53M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-62.21%-75.97M
-15.24%-141.2M
190.47%33M
-93.40%-65.71M
-136.85%-61.66M
-79.88%-46.83M
-36.72%-122.53M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
Basic earnings per share
-29.63%-1.05
-2.56%-2.4
173.17%0.4659
-85.00%-1.11
-100.00%-1.08
-42.11%-0.81
3.70%-2.34
-32.66%-0.6368
4.76%-0.6
10.00%-0.54
Diluted earnings per share
-29.63%-1.05
-2.56%-2.4
173.17%0.4659
-85.00%-1.11
-100.00%-1.08
-42.11%-0.81
3.70%-2.34
-32.66%-0.6368
4.76%-0.6
10.00%-0.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 58.72%89.38M18.06%186.81M-129.20%-13.74M60.98%73.79M111.46%70.45M75.89%56.31M53.96%158.23M51.84%47.06M75.31%45.84M28.20%33.32M
Selling and administrative expenses 70.13%22.87M24.57%61.55M29.45%17.57M11.78%14.8M39.72%15.74M18.60%13.44M51.24%49.41M23.94%13.57M53.40%13.24M71.32%11.27M
-General and administrative expense 70.13%22.87M24.57%61.55M29.45%17.57M11.78%14.8M39.72%15.74M18.60%13.44M51.24%49.41M23.94%13.57M53.40%13.24M71.32%11.27M
Research and development costs 55.15%66.51M107.01%225.26M105.12%68.69M80.96%58.99M148.12%54.71M107.30%42.87M55.22%108.81M67.08%33.49M86.11%32.6M13.60%22.05M
Other operating expenses -------100M--------------------------------
Operating profit -58.72%-89.38M-18.06%-186.81M129.20%13.74M-60.98%-73.79M-111.46%-70.45M-75.89%-56.31M-53.96%-158.23M-51.84%-47.06M-75.31%-45.84M-28.20%-33.32M
Net non-operating interest income expense 42.03%13.6M-0.39%35.87M-14.30%9.19M-31.53%8.18M21.73%8.93M59.39%9.58M168.93%36.01M73.46%10.72M344.61%11.95M159.65%7.34M
Total other finance cost -42.03%-13.6M0.39%-35.87M14.30%-9.19M31.53%-8.18M-21.73%-8.93M-59.39%-9.58M-168.93%-36.01M-73.46%-10.72M-344.61%-11.95M-159.65%-7.34M
Other net income (expense) 10.25M
Special income (charges) ------10.25M------------------0------------
-Gain on sale of property,plant,equipment ------10.25M------------------0------------
Income before tax -62.14%-75.78M-15.11%-140.69M191.28%33.17M-93.61%-65.6M-136.80%-61.52M-79.70%-46.74M-36.73%-122.22M-46.46%-36.34M-44.46%-33.89M-12.17%-25.98M
Income tax 93.88%190K66.13%515K25.00%170K17.39%108K162.26%139K237.93%98K31.36%310K143.59%136K-77.28%92K-55.08%53K
Net income -62.21%-75.97M-15.24%-141.2M190.47%33M-93.40%-65.71M-136.85%-61.66M-79.88%-46.83M-36.72%-122.53M-48.88%-36.48M-42.39%-33.98M-11.83%-26.03M
Net income continuous Operations -62.21%-75.97M-15.24%-141.2M190.47%33M-93.40%-65.71M-136.85%-61.66M-79.88%-46.83M-36.72%-122.53M-48.88%-36.48M-42.39%-33.98M-11.83%-26.03M
Minority interest income
Net income attributable to the parent company -62.21%-75.97M-15.24%-141.2M190.47%33M-93.40%-65.71M-136.85%-61.66M-79.88%-46.83M-36.72%-122.53M-48.88%-36.48M-42.39%-33.98M-11.83%-26.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -62.21%-75.97M-15.24%-141.2M190.47%33M-93.40%-65.71M-136.85%-61.66M-79.88%-46.83M-36.72%-122.53M-48.88%-36.48M-42.39%-33.98M-11.83%-26.03M
Basic earnings per share -29.63%-1.05-2.56%-2.4173.17%0.4659-85.00%-1.11-100.00%-1.08-42.11%-0.813.70%-2.34-32.66%-0.63684.76%-0.610.00%-0.54
Diluted earnings per share -29.63%-1.05-2.56%-2.4173.17%0.4659-85.00%-1.11-100.00%-1.08-42.11%-0.813.70%-2.34-32.66%-0.63684.76%-0.610.00%-0.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +24.74%
Sample Name
Sample Code
 +22.84%
Sample Name
Sample Code
 +19.74%
4
United States Oil Fund LP
USO
+16.51%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+14.47%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.63%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +6.10%
4
Li Auto
LI
+5.40%
5
Vipshop
VIPS
+3.19%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -